SecBot SecBot
Insider Cluster (2 insiders) ·Filed Apr 15, 2026

GILD

GILEAD SCIENCES, INC.
BEARISH
Impact 6/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $846K total
Actionable Insight ▼ Bearish

Traders should monitor for follow-up filings or commentary, as coordinated C-suite selling may signal reduced confidence in near-term prospects, especially if not part of a pre-arranged plan. Compare against historical Form 4 patterns to assess whether this is routine or atypical.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$139.60
T+0 close · Apr 14, 2026 · via day close
Latest settled
−3.41%
T+60 · $134.84
Vs SPY
−10.80%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 15 $139.60entry
  2. T+1 · 7mo ago −0.80%α −1.05% · $138.49
  3. T+5 · 7mo ago −4.83%α −6.47% · $132.85
  4. T+20 · 6mo ago −3.34%α −9.38% · $134.94
  5. T+60 · 4mo ago −3.41%α −10.80% · $134.84
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Gilead Sciences executives, the CFO and Chief Communications Officer, each sold 3,000 shares in open-market transactions on April 15, 2026, totaling $846,000. The sales represent a modest but notable insider selling cluster by C-suite executives, occurring within a single day.

Key Financial Metrics

Direction
selling
Total Value
$845.8K
Insiders
2

Key Facts

  • CFO Andrew D. Dickinson sold 3,000 shares for $422,880 in an open-market transaction.
  • Chief Communications Officer Johanna Mercier sold 3,000 shares for $422,880 in an open-market transaction.
  • Both sales occurred on April 15, 2026, at $140.96 per share.
  • Total value of the cluster: $845,760.

Financial Impact

$845,760 in open-market sales by two C-suite executives

insider ownershipmarket sentiment

Risk Factors

  • Perception of insider skepticism, particularly given participation by CFO
  • Potential for negative market reaction if no public rationale is provided

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
79% bullish (39 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GILD-1776379349175

Track record

30 reports on GILD

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
  2. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
  3. Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
  6. Nov 6, 202610d ago 144 Neutral 2/10 Entry $169.32 Now $167.58 −1.03% settles Feb 5
  7. Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
  8. Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
  9. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
  10. Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (11h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 16, 2026